Attys Denied Fee Set-Aside In Generics Antitrust Case
Lawyers for two sets of litigants suing generic-drug makers in a price-fixing class action can't get a 10% set-aside from any future damages that parties taking their own direct actions ultimately...To view the full article, register now.
Already a subscriber? Click here to view full article